bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales
Go back to bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales| (NASDAQ: BIAF) | Delayed: 6.56 -0.32 (4.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.88 | 52 Week High | $ | |||
| Open | $6.56 | 52 Week Low | $ | |||
| Day High | $7.00 | P/E | N/A | |||
| Day Low | $6.56 | EPS | $ | |||
| Volume | 108,311 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.32 +0.04 (14.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.28 | 52 Week High | $ | |||
| Open | $0.32 | 52 Week Low | $ | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $ | |||
| Volume | 494 | |||||

